entertainment -WSS

entertainment

author：knowledge 2025-09-30 19:25:10 - browse：6

What happens when an approved drug doesn’t work? Why don’t patients want gene therapy? And is MASH still a big deal?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Bioethicist Holly Fernandez Lynch joins us to discuss the case of Amylyx Pharmaceuticals’ treatment for ALS and what its failure means for drug development. We also discuss the latest news in the life sciences, including a tepid reception for gene therapies, the future of CAR-T cancer treatment, and the first approved medicine for a prevalent liver disease.

For more on what we cover, here’s more on Amylyx; here’s the story on hemophilia gene therapy; here’s the news on Madrigal Pharmaceuticals’ drug for MASH; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Sports medicine is finally prioritizing gender equality
Next article： David Sabatini, ex

focus

WSS

Prosthetic arm enables patients to feel the objects they grip

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Childbirth

iTeos Therapeutics debuts first data on TIGIT

Digital health: a case of mistaken identity

Biogen joins immunology wave with $1.15 billion acquisition of HI

focus

entertainment

Wikipedia

Drug repurposing or repositioning? The language matters

Investigation reveals sickle cell patients pressured into sterilizations

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Dark money group runs ads on China biotech bill

Medical records are filled with copy

Bird flu surveillance in wastewater gets boost from consortium

Hepatitis C has a cure — but many Americans still lack access to it

Childbirth

Alkermes shareholders re

Lab trade group sues FDA to halt regulation of lab

hotspot

Childbirth

Akili, maker of video game for ADHD, to be acquired for 34 million

FDA poised to publish guidelines for clinical trial diversity

Biohaven protein

Reports of telehealth's death have been greatly exaggerated

Do more moles mean more problems? Not so, says new study

focus

focus

focus

knowledge